# data[].attributes.body
Eversense is a continuous glucose monitoring system for adults with a fully implantable monitor that can stay in place for up to 90 days. A smart transmitter is replaced daily at the implantation site, and the implant senses and transmits a glucose reading every 5 minutes to an app on your smart phone.

https://www.eversensediabetes.com

# data[].attributes.body
Isabelle - Includer
Carter - Communication
Pablo - Positivity
Louis - Learner
William - Woo

I assembled this team based on their strengths because the change in equipment being used by our patients requires their strengths to ensure this process is smooth.

Isabelle's strength of being an Includer ensures that we will see all sides of this proposed change, because she will encourage each voice to be heard on our team.

Carter's strength of Communication will be a huge asset when it comes to explaining this new innovation not only to the board for approval, but to nurses, doctors, and most importantly the patients who will be using this new technology. His presentation skills will be vital in this effort.

Pablo has the Positivity we need to drive the change we are proposing. He will be able to present with enthusiasm and get other excited about this new technology.

Louis, our Learner, will cover all of the legwork when it comes to data, research, and the facts needed to convince our team that not only is this an excellent product, but it is evidence-based and will improve the health of our clients.

William, who's strength is Winning Others Over, is the glue for our team. He will be able to garner support and buy-in from not only our team, but our board and every person in the decision-making process.

# data[].attributes.body
In my opinion, I think this current innovation will really help Type 1 and Type 2 diabetics take better control of their health. The technology available from this system will ensure  accuracy and improve treatment. I think that the pro's outweigh the con's. My opinion is backed up by the FDA Advisory Committee, who voted 8-0 that the benefits outweigh the risks. (Commissioner, 2018)

# data[].attributes.body
“Eversense Continuous Glucose Monitoring: Long-Term Continuous Glucose Monitor.” Eversense Continuous Glucose Monitoring | Long-Term Continuous Glucose Monitor, www.eversensediabetes.com/.

Commissioner, O. (2018, June 21). FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes. Retrieved October 03, 2020, from https://www.fda.gov/news-events/press-announcements/fda-approves-first-continuous-glucose-monitoring-system-fully-implantable-glucose-sensor-and

# data[].attributes.body
- better control of health
- proven to be safe and effective through clinical research trials
- 24 hour glucose monitoring - every 5 minute transmit for improved accuracy
- less frequent equipment exchange (can last 90 days) as opposed to other CGMS (continuous glucose monitoring systems) that only last 7-14 days.
- app will alert you to high or low blood glucose levels
- more sensitive to fluctuations than other systems
- water-resistant transmitter
- most insurances will cover with a minimal startup cost

# data[].attributes.body
- patients still have to check blood sugar 2x a day (fingerstick) to calibrate the system, if symptoms don't match the reading, and when taking tetracyclines
- requires prescription and health care provider has to insert implant
- smart transmitter (adhesive applied over implant site) has to be changed daily and must be removed during an MRI
- some people may be allergic to the adhesive used to stick the smart transmitter
- must have smart phone or computer access to use the app
- startup cost of at least $99

# data[].attributes.body
FDA
Eversense Continuous Glucose Monitoring System website

Date Published June 21, 2018